{"schema_version":"secwatch.filing_event.v1","accession":"0001437749-25-033604","form_type":"8-K","ticker":"PBYI","cik":"0001401667","company_name":"PUMA BIOTECHNOLOGY, INC.","filed_at":"2025-11-06T23:59:59+00:00","discovered_at":"2026-05-14T18:02:39.313059+00:00","generated_at":"2026-05-16T23:34:58.298309+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Puma raises 2025 guidance; Q3 GAAP net income $8.8M vs $20.3M YoY on lower royalty revenue","bullets":["Q3 GAAP net income $8.8M ($0.17 diluted) vs $20.3M ($0.41) YoY; non-GAAP adj. net income $10.5M ($0.21) vs $22.4M ($0.46).","Q3 product revenue $51.9M (vs $56.1M); total revenue $54.5M (vs $80.5M) driven by lower royalty from China licensee.","Updated FY2025 guidance: product revenue $198-200M, total revenue $220-223M, net income $27-29M (all raised from prior).","Cash & securities $94.4M at Sep 30, 2025; operating cash flow $9.7M in Q3.","Interim data from ALISCA-Breast1 and ALISCA-Lung1 alisertib trials expected H1 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001437749-25-033604","json":"https://secwatch.observer/filing/0001437749-25-033604.json","markdown":"https://secwatch.observer/filing/0001437749-25-033604.md","text":"https://secwatch.observer/filing/0001437749-25-033604.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925033604/0001437749-25-033604-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1401667/000143774925033604/pbyi20250901_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T23:34:58.298309+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}